Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Could disrupting your internal clock be the key to treating Alzheimer’s? A surprising new study, published in the journal ...

Alzheimer's disease is a kind of brain disease that progressively impairs thinking, behaviour, and memory. It is most prevalent in older adults, and people find it more difficult to carry out daily ...

The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...

Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...

The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

A new study reveals that not getting enough of specific stages in the sleep cycle may be linked to cognitive decline and potentially may lead to Alzheimer's disease. Researchers from the Yale School ...

NPR has been following Pansy and Winston Greene, a California couple struggling with an Alzheimer's diagnosis.Three years ago, Pansy learned she had Alzheimer's disease, and over this past summer, the ...

Alzheimer's disease is notorious for scrambling patients' daily rhythms. Restless nights with little sleep and increased ...